Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 36 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10040830

    Methods and compositions for protein delivery

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  2. US 10039819

    Attenuated Mannheimia haemolytica strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  3. US 10035848

    Antibody targeting cell surface deposited complement protein C3d and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  4. US 10035832

    HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  5. US 10035844

    Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  6. US 10035845

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  7. US 10035833

    Vascular endothelial growth factor antagonists and methods of making

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  8. US 10036020

    Compositions and methods for inhibiting JC virus (JCV)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  9. US 10034936

    Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  10. US 10016480

    Peptide-based methods for treating pancreatic cancer

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  11. US 10017762

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  12. US 10016432

    Methanocarba derivatives of pseudoribose that inhibit adenosine kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  13. US 10017543

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  14. US 10017516

    BMP inhibitors and methods of use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  15. US 10004800

    Antibody evolution immunogens

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  16. US 10000813

    Method of diagnosing and treating cancer using B-catenin splice variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  17. US 10001483

    Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  18. US 10000556

    Single-domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  19. US 9993660

    Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections

    The United States of America as represented by the Secretary of Navy · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  20. US 9987330

    Methods of treating or preventing pruritis by blocking natriuretic polypeptide B

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

  21. US 9982025

    Monomeric griffithsin tandemers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 29, 2018 · Expires May 24, 2038

    granted

  22. US 9974801

    Methods of treating and preventing diseases and disorders of the central nervous system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted

  23. US 9976130

    OPAA FL—a mutant enzyme with increased catalytic efficiency on organophosphorus compound GD

    The United States of America as represented by the Secretary of the Army · Granted May 22, 2018 · Expires May 17, 2038

    granted

  24. US 9974789

    Substituted pyrazolopyrimidines as glucocerebrosidase activators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.